50 ML pegloticase 0.16 MG/ML Injection [Krystexxa]

RxNorm concept 2723381, branded drug (sbd). Prescribable name: KRYSTEXXA 8 MG in 50 ML Injection.

RxCUI: 2723381
Term type: Branded drug (SBD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/2723381 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

pegloticase 1011650

Other names

Krystexxa 8 MG per 50 ML Injection

Related concepts

pegloticase 0.16 MG/ML (SCDC, consists of)
pegloticase 0.16 MG/ML [Krystexxa] (SBDC, consists of)
Injection (DF, has dose form)
Krystexxa (BN, has ingredient)
50 ML pegloticase 0.16 MG/ML Injection (SCD, tradename of)

Linked data

NDCs

75987005801

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 2723381 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/2723381 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 2723381. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.